Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Acyline
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Other names | MER-104 |
Routes of administration |
Subcutaneous injection |
Drug class | GnRH antagonist |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C80H102ClN15O14 |
Molar mass | 1533.24 g·mol−1 |
3D model (JSmol) | |
| |
|
Acyline (developmental code name MER-104) is a gonadotropin-releasing hormone analogue (GnRH analogue) and gonadotropin-releasing hormone antagonist (GnRH antagonist) which was never marketed. It has been shown to suppress gonadotropin and testosterone levels in men. Acyline is a peptide and under normal circumstances is not orally active. For this reason, it has instead been administered by subcutaneous injection.
See also
GnRH |
|
||||
---|---|---|---|---|---|
Gonadotropin |
|